A Liquid Chromatography-Quadrupole-Time-Of-Flight Mass Spectrometric Assay for the Quantification of Fabry Disease Biomarker Globotriaosylceramide (GB3) in Fabry Model Mouse
Pharmaceutics - Switzerland
doi 10.3390/pharmaceutics10020069
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 7, 2018
Authors
Publisher
MDPI AG